Nxera’s partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ® in Taiwan, a market with approximately 4–5 million patients, with launch planned during 2026…
RtBrick expands hardware support to include Broadcom Qumran2c+ chipsets, delivering 3x throughput and dense 100G/400G connectivity FREMONT, Calif., April 14,…